№2/2017
Volume 10 Issue 2
|
LYMPHOID TUMORS |
|
| V(D)J Recombination Excision Circles of B- and T-cells as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia
Obraztsov IV, Gordukova MA, Severina NA, Biderman BV, Smirnova SYu, Sudarikov AB, Nikitin EA, Rumyantsev AG |
|
| Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia
Strugov VV, Stadnik EA, Rumyantsev AM, Andreeva TO, Virts YuV, Mirolyubova YuV, Butylin PA, Zaritskey AYu |
|
| Relevance of Positron-Emission Therapy for Optimization of Treatment of Advanced Hodgkin’s Lymphoma Using Intensive ЕАСОРР-14 Program
Demina EA, Leont’eva AA, Tumyan GS, Ryabukhina YuE, Medvedovskaya EG, Trofimova OP, Sotnikov VM, Larionova VB, Paramonova EV, Manzyuk LV, Kokosadze NV, Mukhortova OV, Aslanidi IP, Zaitseva AYu, Radkevich LA, Rudas MS, Manukova VA, Osmanov EA |
|
| Evaluation of Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Using EuroFlow Approaches
Beznos OA, Grivtsova LYu, Popa AV, Shervashidze MA, Serebryakova IN, Baranova OYu, Osmanov EA, Tupitsyn NN |
|
| Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases
Mirolyubova YuV, Stadnik EA, Nikulina TS, Strugov VV, Andreeva TO, Virts YuV, Grozov RV, Zaritskey AYu |
|
| Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report
Volodina OM, Kupryshina NA, Falaleeva NA, Doronin VA, Mozhenkova AV, Frenkel’ MA, Sorokin EN, Kokosadze NV, Tupitsyn NN, Tumyan GS, Osmanov EA |
|
| Prognostic and Differential Diagnostic Value of Standardized Uptake Volume (SUV) of Fluorodeoxyglucose in Patients with Hodgkin’s Lymphoma
Rukavitsyn AA, Kurbanov SI, Rukavitsyn OA |
|
| Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art
Komoza YuV, Komoza VA, Chernavskii SV, Rukavitsyn OA |
|
|
MYELOID TUMORS |
|
| Chromothripsis in Oncology: Literature Review and Case Report
Mamaev NN, Gindina TL, Boichenko EG |
|
| Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
Ionova TI, Bulieva NB, Vinogradova OYu, Gritsenko TA, Kozlova LK, Kuchma GB, Lomaia EG, Machyulaitene ER, Nikitina TP, Novitskaya NV, Rodionova AYu, Usacheva EI, Shneider TV |
|
| A Case Report of Myeloid Sarcoma in a Child
Valiev TT, Kovrigina AM, Panferova TR, Ushakova TL, Serebryakova IN, Tupitsyn NN, Grivtsova LYu, Matveeva II, Mikhailova EV, Popa AV, Mentkevich GL |
|
| REVIEWS | |
| Cytogenetic and Molecular Genetic Prognostic Factors of Acute Myeloid Leukemia
Misyurin AV |
|
| Molecular Genetic Abnormalities in the Pathogenesis of Hematologic Malignancies and Corresponding Changes in Cell Signaling Systems
Tilova LR, Savinkova AV, Zhidkova EM, Borisova OI, Fetisov TI, Kuzin KA, Vlasova OA, Antipova AS, Baranova OYu, Kirsanov KI, Belitskii GA, Yakubovskaya MG, Lesovaya EA |
|
| PROBLEMS OF POPULATION HEMATOLOGY | |
| Concept, Principles, and Objectives of Population Hematology
Kulikov SM, Garmaeva TTs, Rusinov MA, Parovichnikova EN |
|
|
CONGRESSES, CONFERENCES, SYMPOSIA |
|
| Materials of the 58th Annual American Hematology Society Meeting (December, 2016; San Diego) |
|
